Annual Operating Expenses
$427.44 M
+$206.10 M+93.12%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual total operating expenses is $427.44 million, with the most recent change of +$206.10 million (+93.12%) on December 31, 2023.
- During the last 3 years, AXSM annual operating expenses has risen by +$328.35 million (+331.38%).
- AXSM annual operating expenses is now at all-time high.
Performance
AXSM Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$142.56 M
-$12.44 M-8.03%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly total operating expenses is $142.56 million, with the most recent change of -$12.44 million (-8.03%) on September 30, 2024.
- Over the past year, AXSM quarterly operating expenses has increased by +$23.34 million (+19.58%).
- AXSM quarterly operating expenses is now -8.03% below its all-time high of $155.00 million, reached on June 30, 2024.
Performance
AXSM Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AXSM Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +93.1% | +19.6% |
| 3 y3 years | +331.4% | +326.7% |
| 5 y5 years | +1210.0% | +658.0% |
AXSM Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +242.8% | -8.0% | +337.2% |
| 5 y | 5-year | at high | +537.0% | -8.0% | +701.8% |
| alltime | all time | at high | >+9999.0% | -8.0% | +8302.1% |
Axsome Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $142.56 M(-8.0%) |
| Jun 2024 | - | $155.00 M(+12.8%) |
| Mar 2024 | - | $137.39 M(+15.2%) |
| Dec 2023 | $427.44 M(+93.1%) | $119.22 M(+5.0%) |
| Sep 2023 | - | $113.56 M(+12.3%) |
| Jun 2023 | - | $101.11 M(+8.1%) |
| Mar 2023 | - | $93.56 M(+20.3%) |
| Dec 2022 | $221.34 M(+77.5%) | $77.80 M(+35.6%) |
| Sep 2022 | - | $57.38 M(+19.8%) |
| Jun 2022 | - | $47.88 M(+25.0%) |
| Mar 2022 | - | $38.29 M(+17.4%) |
| Dec 2021 | $124.71 M(+25.9%) | $32.61 M(-2.4%) |
| Sep 2021 | - | $33.41 M(+8.3%) |
| Jun 2021 | - | $30.85 M(+10.8%) |
| Mar 2021 | - | $27.84 M(+0.6%) |
| Dec 2020 | $99.09 M(+47.7%) | $27.69 M(+31.1%) |
| Sep 2020 | - | $21.13 M(+18.8%) |
| Jun 2020 | - | $17.78 M(-45.3%) |
| Mar 2020 | - | $32.49 M(+33.0%) |
| Dec 2019 | $67.11 M | $24.43 M(+29.9%) |
| Sep 2019 | - | $18.81 M(+39.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $13.45 M(+29.0%) |
| Mar 2019 | - | $10.42 M(+10.3%) |
| Dec 2018 | $32.63 M(+21.0%) | $9.45 M(+17.7%) |
| Sep 2018 | - | $8.03 M(+0.5%) |
| Jun 2018 | - | $7.99 M(+11.5%) |
| Mar 2018 | - | $7.16 M(+11.2%) |
| Dec 2017 | $26.96 M(-0.4%) | $6.44 M(+5.8%) |
| Sep 2017 | - | $6.09 M(-9.8%) |
| Jun 2017 | - | $6.75 M(-12.0%) |
| Mar 2017 | - | $7.67 M(+7.3%) |
| Dec 2016 | $27.07 M(+194.3%) | $7.15 M(-0.8%) |
| Sep 2016 | - | $7.21 M(+5.6%) |
| Jun 2016 | - | $6.83 M(+16.1%) |
| Mar 2016 | - | $5.88 M(+86.5%) |
| Dec 2015 | $9.20 M(+67.6%) | $3.15 M(+55.9%) |
| Sep 2015 | - | $2.02 M(-2.9%) |
| Jun 2015 | - | $2.08 M(+7.8%) |
| Mar 2015 | - | $1.93 M(-0.8%) |
| Dec 2014 | $5.49 M(+198.4%) | $1.95 M(+14.8%) |
| Sep 2014 | - | $1.70 M |
| Dec 2013 | $1.84 M | - |
FAQ
- What is Axsome Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Axsome Therapeutics?
- What is Axsome Therapeutics annual operating expenses year-on-year change?
- What is Axsome Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly operating expenses year-on-year change?
What is Axsome Therapeutics annual total operating expenses?
The current annual operating expenses of AXSM is $427.44 M
What is the all time high annual operating expenses for Axsome Therapeutics?
Axsome Therapeutics all-time high annual total operating expenses is $427.44 M
What is Axsome Therapeutics annual operating expenses year-on-year change?
Over the past year, AXSM annual total operating expenses has changed by +$206.10 M (+93.12%)
What is Axsome Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of AXSM is $142.56 M
What is the all time high quarterly operating expenses for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly total operating expenses is $155.00 M
What is Axsome Therapeutics quarterly operating expenses year-on-year change?
Over the past year, AXSM quarterly total operating expenses has changed by +$23.34 M (+19.58%)